Oracle Corp: Form 10-Q for the period ended Aug 31, 2024
Filed with the SEC on Sep 10, 2024 and accepted by EDGAR at Sep 10, 2024, 06:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-06-01 to 2024-08-31 | $13.31bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2024-06-01 to 2024-08-31 | $2.31bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-06-01 to 2024-08-31 | $3.99bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-06-01 to 2024-08-31 | $842.0m | us-gaap:InterestExpense |
| Income tax | 3 months2024-06-01 to 2024-08-31 | $240.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-06-01 to 2024-08-31 | $2.93bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-06-01 to 2024-08-31 | $1.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-06-01 to 2024-08-31 | $1.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-06-01 to 2024-08-31 | 2,851,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-06-01 to 2024-08-31 | $7.43bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-06-01 to 2024-08-31 | $2.30bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-06-01 to 2024-08-31 | $1.10bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-06-01 to 2024-08-31 | $150.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-08-31 | $10.62bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-08-31 | $23.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-08-31 | $144.21bn | us-gaap:Assets |
| Current liabilities | At period end2024-08-31 | $32.05bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-08-31 | $10.82bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-09-06 | 2,770,968,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-104905. Last ingested by Listed: Oct 27, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.